🇺🇸 FDA
Patent

US 6610718

Processes for making- and a new crystalline form of- leflunomide

expired A61KA61K31/42A61P

Quick answer

US patent 6610718 (Processes for making- and a new crystalline form of- leflunomide) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/42, A61P, A61P19/02, A61P29/00